Daniel Nadler

Daniel Nadler is a prominent technology entrepreneur and the founder of OpenEvidence, a medical AI company launched in October 2021.13 Here are some key details about Nadler:

Background and Education

Daniel Nadler holds a Ph.D. from Harvard University, which he completed in 2016.34 His doctoral thesis focused on new econometric and statistical approaches to modeling low probability, high impact events.4

Professional Achievements

Kensho Technologies: Before founding OpenEvidence, Nadler co-founded Kensho Technologies in 2013 while still a Ph.D. student at Harvard.34 Kensho developed machine learning systems for Fortune 500 companies and early warning applications for the U.S. Department of Defense.3 In 2018, Kensho was acquired by S&P Global for $550 million, making it the most valuable privately owned artificial intelligence company at the time.4

OpenEvidence: In October 2021, Nadler founded OpenEvidence, an AI-powered platform that aggregates, synthesizes, and visualizes peer-reviewed medical literature.12 The company aims to help healthcare professionals make evidence-based decisions and stay up-to-date with the latest medical research.1 As of July 2023, OpenEvidence was valued at $425 million.1

Other Activities

Nadler has also been involved in various artistic and cultural pursuits:

• He serves on the Digital Art Committee of the Whitney Museum4
• In 2021, he was elected to the Board of Directors of MoMA PS14
• He is a published poet, with his debut collection "Lacunae: 100 Imagined Ancient Love Poems" released in 20164
• Nadler has been involved in film production, serving as executive producer for "Motherless Brooklyn" and producer for "Palmer"4

Daniel Nadler's diverse background in technology, academia, and the arts has contributed to his success as an entrepreneur and innovator in the field of artificial intelligence.